Financials
Financial year 2025
De Mulder-Demey, medische oncologie - MKA from Kruisem, company number BE0782632523, closed financial year 2025 with a result of € 296,355 after tax. For that financial year De Mulder-Demey, medische oncologie - MKA recorded a gross margin of € 399,157 and equity of € 20,051. Compared with financial year 2024, the result moved from € 44,510 to € 296,355. Profitable, and profit is growing. The buffer shrank hard: equity is 80 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on February 17, 2026.
€ 20,051
▼ 80% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 296,355
▲ € 251,845 vs 2024
Profit after tax over the fiscal year.
€ 140,211
▲ 30% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 376,761 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 8,790
▼ 42% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 20,000
Loans from banks and other lenders, long and short.
€ 1,275
▲ € 1,248 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 15,409
▲ 276% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 27,511 | € 55,136 | € 63,599 | € 399,157 | ▲ € 335,559 |
| Profit after taxes | € 16,651 | € 37,557 | € 44,510 | € 296,355 | ▲ € 251,845 |
| Equity | € 20,051 | € 55,947 | € 100,457 | € 20,051 | ▼ 80% |
| Total debts | € 30,382 | € 31,312 | € 27,994 | € 134,780 | ▲ € 106,786 |
| Cash | € 20,801 | € 28,901 | € 107,683 | € 140,211 | ▲ 30% |
| Retained profit | € 15,051 | € 50,947 | € 95,457 | € 15,051 | ▼ 84% |
| Dividend | € 1,600 | € 1,660 | € 0 | € 376,761 | |
| Bank debt | € 0 | € 0 | € 20,000 | € 20,000 | |
| Balance sheet total | € 50,433 | € 87,259 | € 128,451 | € 154,831 | ▲ 21% |
Key figures of De Mulder-Demey, medische oncologie - MKA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to De Mulder-Demey, medische oncologie - MKA?
What happened at De Mulder-Demey, medische oncologie - MKA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 296,355 (▲ € 251,845 vs 2024). Source: NBB ↗
- New establishment in Kruisem. KBO
- Start of the company according to the CBE. KBO
In short
From € 16,651 profit in 2022 to € 296,355 profit in 2025.
Paid € 125,280 in corporate taxes since 2022.
Best year ever: 2025, with € 296,355 profit.
Paid out € 380,021 in dividends to the owners in total.
A new publication or filing at De Mulder-Demey, medische oncologie - MKA? We notify you, reason included.
Follow De Mulder-Demey, medische oncologie - MKADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind De Mulder-Demey, medische oncologie - MKA are Neil Dirk Demey and Elien De Mulder.
Directors
According to the 2025 annual accounts
Neil Dirk Demey
Director
Elien De Mulder
Director
Establishments
Establishment units
Physical locations of this company
Boeregemstraat 48
9750 Kruisem
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0782.632.523
- VAT number
- BE 0782.632.523
- Registered office
- Boeregemstraat 48, 9750 Kruisem
- Names & denominations
- De Mulder-Demey, medische oncologie - MKA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 25 February 2022
- Peppol
- Active · Active since 2 Jan 2025
- Activities · NACE
Activiteiten van medisch specialisten